This topic contains a solution. Click here to go to the answer

Author Question: During therapy with hematopoietic drugs, the nurse will monitor the patient for which adverse ... (Read 68 times)

littleanan

  • Hero Member
  • *****
  • Posts: 575
During therapy with hematopoietic drugs, the nurse will monitor the patient for which adverse effects?
 
  (Select all that apply.)
  a. Hypotension
  b. Edema
  c. Diarrhea
  d. Black, tarry stools
  e. Nausea and vomiting
  f. Headache

Question 2

A patient must be treated immediately for acute organ transplant rejection.
 
  The nurse anticipates that muromonab-CD3 (Orthoclone OKT3) will be ordered. What is the priority assessment before beginning drug therapy with muromonab-CD3?
  a. Serum potassium level
  b. Fluid volume status
  c. Electrocardiogram
  d. Blood glucose level



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

hanadaa

  • Sr. Member
  • ****
  • Posts: 339
Answer to Question 1

ANS: B, C, E, F

Answer to Question 2

ANS: B




littleanan

  • Member
  • Posts: 575
Reply 2 on: Jul 23, 2018
Gracias!


ryhom

  • Member
  • Posts: 366
Reply 3 on: Yesterday
Excellent

 

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

More than 30% of American adults, and about 12% of children utilize health care approaches that were developed outside of conventional medicine.

Did you know?

Sildenafil (Viagra®) has two actions that may be of consequence in patients with heart disease. It can lower the blood pressure, and it can interact with nitrates. It should never be used in patients who are taking nitrates.

Did you know?

Before a vaccine is licensed in the USA, the Food and Drug Administration (FDA) reviews it for safety and effectiveness. The CDC then reviews all studies again, as well as the American Academy of Pediatrics and the American Academy of Family Physicians. Every lot of vaccine is tested before administration to the public, and the FDA regularly inspects vaccine manufacturers' facilities.

Did you know?

Though newer “smart” infusion pumps are increasingly becoming more sophisticated, they cannot prevent all programming and administration errors. Health care professionals that use smart infusion pumps must still practice the rights of medication administration and have other professionals double-check all high-risk infusions.

For a complete list of videos, visit our video library